In reply

JAMA

Volumn 299, Issue 13, 2008, Pages 1542-

  Pandharipande, Pratik P ^a   Girard, Timothy D ^a   Ely, E Wesley ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMEDETOMIDINE; FENTANYL; LORAZEPAM;

AGITATION; ARTIFICIAL VENTILATION; BRAIN DYSFUNCTION; CLINICAL TRIAL; COMA; CONTINUOUS INFUSION; DELIRIUM; DRUG EFFECT; DRUG HALF LIFE; DRUG USE; HUMAN; INTENSIVE CARE UNIT; LETTER; OUTCOME ASSESSMENT; PAIN; PRIORITY JOURNAL; PROTECTION; SEDATION;

EID: 41649118835     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Weinert CR, Calvin AD. Epidemiology of sedation and sedation adequacy for mechanically ventilated patients in a medical and surgical intensive care unit. Crit Care Med. 2007;35(2):393-401.
2. Payen JF, Chanques G, Mantz J, et al. Current practices in sedation and analgesia for mechanically ventilated critically ill patients: a prospective multicenter patient-based study. Anesthesiology. 2007;106(4):687-695.
3. Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002;30(1):119-141.
4. Jackson JC, Gordon SM, Girard TD, et al. Delirium as a risk factor for long term cognitive impairment in mechanically ventilated ICU survivors. Am J Respir Crit Care Med. 2007;175:A22.
5. Pandharipande P, Shintani A, Peterson J, et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology. 2006;104(1):21-26.
6. Girard TD, Kress JP, Fuchs BD, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet. 2008;371(9607):126-134.